IdentificationGeneric Name(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATEDrugBank Accession NumberDB04683BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


Download MOLSDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE (DB04683)× CloseWeightAverage: 746.9913 Monoisotopic: 746.509785132 Chemical FormulaC40H75O10PSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUSteroidogenic factor 1Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as phosphatidylglycerols. These are glycerophosphoglycerols in which two fatty acids are bonded to the 1-glycerol moiety through ester linkages. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions.KingdomOrganic compoundsSuper ClassLipids and lipid-like moleculesClassGlycerophospholipidsSub ClassGlycerophosphoglycerolsDirect ParentPhosphatidylglycerolsAlternative ParentsFatty acid esters / Dialkyl phosphates / Dicarboxylic acids and derivatives / Secondary alcohols / Carboxylic acid esters / 1,2-diols / Primary alcohols / Organic oxides / Hydrocarbon derivatives / Carbonyl compoundsSubstituents1,2-diacylglycerophosphoglycerol / 1,2-diol / Alcohol / Aliphatic acyclic compound / Alkyl phosphate / Carbonyl group / Carboxylic acid derivative / Carboxylic acid ester / Dialkyl phosphate / Dicarboxylic acid or derivativesMolecular FrameworkAliphatic acyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyQGIXWNRQEFVVRM-CTDKCSBDSA-NInChIInChI=1S/C40H75O10P/c1-3-5-7-9-11-13-15-17-18-20-21-23-25-27-29-31-39(43)47-35-38(36-49-51(45,46)48-34-37(42)33-41)50-40(44)32-30-28-26-24-22-19-16-14-12-10-8-6-4-2/h14,16-18,37-38,41-42H,3-13,15,19-36H2,1-2H3,(H,45,46)/b16-14-,18-17-/t37-,38-/m1/s1IUPAC Name[(2R)-2,3-dihydroxypropoxy][(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic acidSMILESCCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](CO[P@](O)(=O)OC[C@H](O)CO)OC(=O)CCCCCCC\C=C/CCCCCCReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound5288113PubChem Substance46507864ChemSpider4450344ZINCZINC000053683609PDBe LigandDR9PDB Entries1ymt / 7kc4 / 7z0sClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.000105 mg/mLALOGPSlogP8.02ALOGPSlogP11.1ChemaxonlogS-6.8ALOGPSpKa (Strongest Acidic)1.89ChemaxonpKa (Strongest Basic)-3ChemaxonPhysiological Charge-1ChemaxonHydrogen Acceptor Count6ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area148.82 Å2ChemaxonRotatable Bond Count40ChemaxonRefractivity206.74 m3·mol-1ChemaxonPolarizability89.88 Å3ChemaxonNumber of Rings0ChemaxonBioavailability0ChemaxonRule of FiveNoChemaxonGhose FilterNoChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.5761Blood Brain Barrier+0.8748Caco-2 permeable-0.6215P-glycoprotein substrateSubstrate0.5557P-glycoprotein inhibitor INon-inhibitor0.7535P-glycoprotein inhibitor IINon-inhibitor0.8996Renal organic cation transporterNon-inhibitor0.954CYP450 2C9 substrateNon-substrate0.889CYP450 2D6 substrateNon-substrate0.8292CYP450 3A4 substrateNon-substrate0.5805CYP450 1A2 substrateNon-inhibitor0.8116CYP450 2C9 inhibitorNon-inhibitor0.8471CYP450 2D6 inhibitorNon-inhibitor0.8931CYP450 2C19 inhibitorNon-inhibitor0.8047CYP450 3A4 inhibitorNon-inhibitor0.6986CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9696Ames testNon AMES toxic0.8494CarcinogenicityNon-carcinogens0.6453BiodegradationNot ready biodegradable0.5169Rat acute toxicity2.0274 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.8742hERG inhibition (predictor II)Non-inhibitor0.6753  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Steroidogenic factor 1KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionZinc ion bindingSpecific FunctionTranscriptional activator. Seems to be essential for sexual differentiation and formation of the primary steroidogenic tissues. Binds to the Ad4 site found in the promoter region of steroidogenic P...Gene NameNR5A1Uniprot IDQ13285Uniprot NameSteroidogenic factor 1Molecular Weight51635.47 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 11, 2007 17:49 / Updated at June 12, 2020 16:52 